Moderna’s Covid vaccine for children has been given full FDA approval, making it the first such shot for kids in the U.S.

Moderna, Inc. (MRNA) on Thursday announced that the U.S. Food and Drug Administration (FDA) has fully approved its COVID-19 ...

Fresh off of the heels of a shakeup at the CDC over vaccine recommendations, many Americans still question the necessity and ...

Moderna is seeking emergency use authorization from the FDA for its Covid-19 vaccine for children 6 months through 5 years of age.

The FDA this week fully approved Moderna’s COVID-19 vaccine for children aged 6 months to 11 years but limited the approval ...

The U.S. Food and Drug Administration has granted full approval for Moderna's MRNA.O COVID-19 vaccine, Spikevax, in children aged 6 months through 11 years who are at an increased risk of the disease, ...

The U.S. Food and Drug Administration approved "Spikevax," Moderna's vaccine for children aged 6 months to 11 years old. The ...

While an emergency use authorization may be the speediest way for public health officials to begin a vaccination campaign, it may not end up shaving that much time off of a more traditional route to ...

What is an emergency use authorization? An emergency use authorization is a tool that the FDA uses to strengthen the nation’s response to public health emergencies such as COVID-19.

Emergency use authorization can be granted when a vaccine meets certain standards during a time when there is extreme risk to public health.

To win emergency use authorization, or EUA, drug or device makers may present the FDA with less evidence of a product’s safety and effectiveness than is required for full approval.

Emergency use authorization can be granted when a vaccine meets certain standards during a time when there is extreme risk to public health.